Parker Geoffrey M.

SEC source: 0000899243-23-011188 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,030

F1 · kind: On April 6, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.825 per share. As one of the PIPE Investors, the Reporting Person acquired 303,030 shares of Issuer common stock on April 10, 2023 for $0.825 per share.

SEC source: 0001585364-23-000008 · wf-form4_167819327700302.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 15,879

F1 · ownership.nature: Revocable trust in which Geoffrey Parker and Jill Parker are the trustees.

SEC source: 0000899243-22-034084 · doc4.xml · derivative · entry 9

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,723 shares

Expires not disclosed

F4 · derivative.exercise_price: At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date.

F4 · price: At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date.

F4 · derivative.exercise_date: At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date.

F4 · derivative.expiration_date: At the Effective Time, each restricted stock unit of the Company held by the Reporting Person that was outstanding immediately prior to the Effective Time and that was (A) granted prior to August 3, 2022 or granted after August 3, 2022 and specified in the disclosure schedules delivered by the Company to Parent in connection with the Merger Agreement and/or (B) granted to a non-employee member of the Board became fully vested and was cancelled and converted into the right to receive an amount in cash, less applicable withholding taxes and without interest, equal to (x) the total number of Shares underlying such restricted stock unit multiplied by (y) $52.00. The restricted stock units did not have an expiration date.

SEC source: 0000899243-22-034084 · doc4.xml · derivative · entry 8

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires not disclosed

F3 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.expiration_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

SEC source: 0000899243-22-034084 · doc4.xml · derivative · entry 7

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,352 shares

Expires not disclosed

F3 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.expiration_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

SEC source: 0000899243-22-034084 · doc4.xml · derivative · entry 6

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,287 shares

Expires not disclosed

F3 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.expiration_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

SEC source: 0000899243-22-034084 · doc4.xml · derivative · entry 5

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,504 shares

Expires not disclosed

F3 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.expiration_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

SEC source: 0000899243-22-034084 · doc4.xml · derivative · entry 4

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,342 shares

Expires not disclosed

F3 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

F3 · derivative.expiration_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each stock option of the Company ("Company Option") held by the Reporting Person that remained outstanding as of immediately prior to the Effective Time vested in full and was canceled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the number of Shares underlying such Company Option immediately prior to the Effective Time by (y) the amount, if any, by which the Merger Consideration exceeded the exercise price of such Company Option.

SEC source: 0000899243-22-034084 · doc4.xml · nonDerivative · entry 3

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Delaware Charter Guarantee & Trust Company, Trustee FBO Mr. Geoffrey Monroe Parker IRA

Disclosed balance after: 0

F1 · price: Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 3, 2022, among Amgen Inc. ("Parent"), Carnation Merger Sub, Inc. ("Merger Sub") and ChemoCentryx, Inc. (the "Company"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Shares," and each such share, a "Share") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,

F2 · price: (Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the "Merger Consideration"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares.

SEC source: 0000899243-22-034084 · doc4.xml · nonDerivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 0

F1 · price: Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 3, 2022, among Amgen Inc. ("Parent"), Carnation Merger Sub, Inc. ("Merger Sub") and ChemoCentryx, Inc. (the "Company"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Shares," and each such share, a "Share") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,

F2 · price: (Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the "Merger Consideration"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares.

SEC source: 0000899243-22-034084 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Reflects the disposition of securities pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 3, 2022, among Amgen Inc. ("Parent"), Carnation Merger Sub, Inc. ("Merger Sub") and ChemoCentryx, Inc. (the "Company"), pursuant to which, on October 20, 2022, Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), each issued and outstanding share of common stock, par value $0.001 per share, of the Company (collectively, the "Shares," and each such share, a "Share") (other than any such Shares (i) held by the Company as treasury stock or owned by Parent or Merger Sub, (ii) held by any subsidiary of the Company or Parent (other than Merger Sub) or (iii) as to which appraisal rights have been properly exercised,

F2 · price: (Continued from Footnote 1) and not withdrawn, in accordance with the Delaware General Corporation Law) was thereupon canceled and converted into the right to receive $52.00 in cash, without interest (the "Merger Consideration"). As a result of the Merger, the Reporting Person no longer beneficially owns, directly or indirectly, any Shares.

SEC source: 0000899243-22-022382 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0000899243-22-021940 · doc4.xml · derivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2032-06-08

F1 · derivative.exercise_date: The stock option vests in full on the earlier of the first anniversary of the grant date and the Issuer's next annual meeting of stockholders, provided that the Reporting Person continues to serve as a director of the Issuer on such vesting date. The stock option was granted on June 9, 2022.

SEC source: 0001209191-22-033042 · doc4.xml · derivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,342

Underlying: Common Stock · 8,342 shares

Expires 2032-05-26

F4 · price: Not applicable.

F3 · derivative.exercise_date: The option granted on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.

SEC source: 0001209191-22-033042 · doc4.xml · derivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,723

Underlying: Common Stock · 15,723 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F2 · derivative.exercise_date: The restricted stock units awarded on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.

F2 · derivative.expiration_date: The restricted stock units awarded on May 26, 2022, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following the vesting date.

SEC source: 0001209191-22-031761 · doc4.xml · derivative · entry 4

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,726 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.

F3 · derivative.expiration_date: 100% of the restricted stock units vested on May 20, 2022. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.

SEC source: 0001209191-22-031761 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 21,076

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares were acquired upon vesting of restricted stock units awarded on May 20, 2021.

SEC source: 0001585364-22-000052 · wf-form4_165298275391518.xml · derivative · entry 6

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 6,599 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2021.

F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F5 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022.

F5 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022.

SEC source: 0001585364-22-000052 · wf-form4_165298275391518.xml · derivative · entry 5

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,778

Underlying: Ordinary Shares · 7,778 shares

Expires not disclosed

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F4 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023.

F4 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023.

SEC source: 0001585364-22-000052 · wf-form4_165298275391518.xml · nonDerivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,661

SEC source: 0001585364-22-000052 · wf-form4_165298275391518.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,829

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2021.

SEC source: 0001209191-22-026584 · doc4.xml · derivative · entry 4

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2022-06-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Not applicable.

F1 · derivative.exercise_date: As of May 2, 2022, and prior to this transaction, the exercised options were fully vested.

SEC source: 0001209191-22-026584 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,413

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-22-012959 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.08 to $2.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001595585-22-000015 · wf-form4_164625771128910.xml · derivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · COO, CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 256,000

Underlying: Common Stock · 256,000 shares

Expires 2032-02-27

F1 · derivative.exercise_date: The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on February 28, 2023, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date.

SEC source: 0001595585-22-000003 · wf-form4_164133106298138.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · COO, CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,617

F1 · shares: The shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs granted on September 10, 2020.

F2 · balance_after: This amount includes 1,664 shares acquired on November 30, 2021 under the Tricida, Inc. 2018 Employee Stock Purchase Plan. These acquisitions are exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from Section 16(a) pursuant to Rule 16a-3(f)(1)(i)(B).

SEC source: 0001585364-21-000122 · wf-form4_163976246750439.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 10,879

F1 · ownership.nature: Revocable trust in which Geoffrey Parker and Jill Parker are the trustees.

SEC source: 0000899243-21-048609 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Parker Trust

Disclosed balance after: 53,333

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.7100 to $5.3050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: These shares are owned directly by the Geoffrey M. Parker and Jill G. Parker Rev Trust dtd 1/27/00 (the "Parker Trust"), and indirectly by the Reporting Person and his spouse, Jill G. Parker, as trustees of the Parker Trust.

SEC source: 0001595585-21-000132 · wf-form4_163718453716271.xml · derivative · entry 5

Parker Geoffrey M. · CIK 0001491874 · COO, CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Indirect · By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00

Disclosed balance after: 166,667

Underlying: Common Stock · 166,667 shares

Expires not disclosed

F1 · price: These shares of common stock and these common warrants were acquired directly from Tricida, Inc. (the "Issuer") in a registered direct offering. For each share purchased in the registered direct offering, at a price of $6.00 per share of common stock, the purchaser received one warrant.

F6 · derivative.exercise_date: The common warrants may be exercised for shares of common stock at any time on or after the date that is six months after the date of their issuance.

F7 · derivative.expiration_date: The expiration date is the earliest of: (a) the third anniversary of the date of their issuance, (b) immediately prior to the closing of a fundamental transaction or (c) the occurrence of certain other events. A "fundamental transaction" includes a consolidation or merger, the sale, transfer or other disposition of all or substantially all of the Issuer's properties or assets, the acquisition of more than 50% of the Issuer's outstanding common stock, any reorganization, recapitalization or reclassification of the Issuer's common stock or any person or group becoming the beneficial owner of 50% of the voting power represented by the Issuer's outstanding common stock.

F2 · ownership.nature: Shares held by the Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00.

SEC source: 0001595585-21-000132 · wf-form4_163718453716271.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · COO, CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Indirect · By Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00

Disclosed balance after: 261,667

F1 · price: These shares of common stock and these common warrants were acquired directly from Tricida, Inc. (the "Issuer") in a registered direct offering. For each share purchased in the registered direct offering, at a price of $6.00 per share of common stock, the purchaser received one warrant.

F2 · ownership.nature: Shares held by the Geoffrey M. Parker and Jill Gofen Parker Rev. Trust dated 1/27/00.

SEC source: 0000899243-21-042253 · doc4.xml · derivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,300

Underlying: Common Stock · 28,300 shares

Expires 2031-10-27

F4 · derivative.exercise_date: Following the Issuer's filing of Form S-8 to register the shares subject to the stock option, the stock option vests as to 1/3 of the shares subject to the stock option on October 28, 2022 and the remaining shares vest in 24 equal monthly installments thereafter, provided the Reporting Person continues to have a service relationship with Issuer on each vesting date. The stock option was granted on October 28, 2021.

SEC source: 0000899243-21-042253 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Parker Trust

Disclosed balance after: 33,333

F1 · kind: Pursuant to the Agreement and Plan of Merger, dated April 6, 2021, as amended (the "Merger Agreement"), by and among Mountain Crest Acquisition Corp. II ("Issuer"), MCAD Merger Sub Inc. ("Merger Sub") and Better Therapeutics, Inc. ("BTX"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the "Business Combination").

F2 · kind: At the effective time of the Business Combination, each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475, with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc.

F1 · price: Pursuant to the Agreement and Plan of Merger, dated April 6, 2021, as amended (the "Merger Agreement"), by and among Mountain Crest Acquisition Corp. II ("Issuer"), MCAD Merger Sub Inc. ("Merger Sub") and Better Therapeutics, Inc. ("BTX"), on October 28, 2021, Merger Sub merged with and into BTX, with BTX surviving the merger as a wholly-owned subsidiary of Issuer (such merger and the other transactions contemplated by the Merger Agreement, the "Business Combination").

F2 · price: At the effective time of the Business Combination, each share of BTX common stock (including shares of BTX common stock resulting from the conversion of BTX preferred stock and BTX Simple Agreements for Future Equity) was converted into a right to receive the number of shares of Issuer common stock equal to the product of the number of shares of BTX common stock and 0.9475, with fractional shares rounded to the nearest whole share. Issuer subsequently changed its name to Better Therapeutics, Inc.

F3 · ownership.nature: These shares are owned directly by the Geoffrey M. Parker and Jill G. Parker Rev Trust dtd 1/27/00 (the "Parker Trust"), and indirectly by the Reporting Person and his spouse, Jill G. Parker, as trustees of the Parker Trust.

SEC source: 0001209191-21-035555 · doc4.xml · derivative · entry 7

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,660 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F6 · derivative.exercise_date: 100% of the restricted stock units vested on May 21, 2021. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.

F6 · derivative.expiration_date: 100% of the restricted stock units vested on May 21, 2021. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.

SEC source: 0001209191-21-035555 · doc4.xml · nonDerivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 13,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Shares were acquired upon vesting of restricted stock units awarded on May 21, 2020.

SEC source: 0001209191-21-035555 · doc4.xml · derivative · entry 6

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,504

Underlying: Common Stock · 4,504 shares

Expires 2031-05-20

F5 · price: Not applicable.

F4 · derivative.exercise_date: The option granted on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date.

SEC source: 0001209191-21-035555 · doc4.xml · derivative · entry 5

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,726

Underlying: Common Stock · 7,726 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F3 · derivative.exercise_date: The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.

F3 · derivative.expiration_date: The restricted stock units awarded on May 20, 2021, vests on the first anniversary of the grant date, subject to the Reporting Person's continued service to the Company on such date. Shares will be delivered to the Reporting Person within thirty (30) days following vest date.

SEC source: 0001585364-21-000085 · wf-form4_162144355090726.xml · derivative · entry 4

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,599

Underlying: Ordinary Shares · 6,599 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022.

F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022.

SEC source: 0001585364-21-000059 · wf-form4_162075939646305.xml · derivative · entry 5

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 5,804 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F1 · kind: Vesting of service-based restricted stock units granted on 7 May 2020.

F3 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.

F4 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021.

F4 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021.

SEC source: 0001585364-21-000059 · wf-form4_162075939646305.xml · nonDerivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,459

SEC source: 0001585364-21-000059 · wf-form4_162075939646305.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Vesting of service-based restricted stock units granted on 7 May 2020.

SEC source: 0001585364-21-000041 · wf-form4_161609309575917.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Revocable Trust

Disclosed balance after: 2,650

F1 · ownership.nature: Revocable trust in which Geoffrey Parker and Jill Parker are the trustees.

SEC source: 0001209191-21-035555 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 8,690

SEC source: 0001209191-21-018788 · doc4.xml · nonDerivative · entry 3

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 12,690

F3 · price: Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $55.27 to $56.25 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-018788 · doc4.xml · nonDerivative · entry 2

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 26,020

F2 · price: Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $56.26 to $57.20 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-018788 · doc4.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 42,690

F1 · price: Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $60.03 to $60.34 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001595585-21-000022 · wf-form4_161118093167557.xml · derivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,000

Underlying: Common Stock · 216,000 shares

Expires 2031-01-16

F1 · derivative.exercise_date: The option to purchase common stock will vest as follows: (a) 25% of the shares subject to the options shall vest on January 17, 2022, and (b) the remaining 75% vest in 36 equal monthly installments thereafter, subject to reporting person's continuous service as of each vesting date.

SEC source: 0001595585-20-000153 · wf-form4_160764758246624.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · CFO and EVP

10b5-1 filing: Not disclosed

Ownership: Indirect · By Equity Trust Company, Trustee of the Geoffrey M. Parker Roth IRA

Disclosed balance after: 40,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.54 to $6.92, inclusive. The reporting person undertakes to provide to Tricida, Inc., any security holder of Tricida, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

F2 · ownership.nature: Shares held by Equity Trust Company, Trustee of the Geoffrey M. Parker Roth IRA

SEC source: 0001595585-20-000121 · wf-form4_160013002118302.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Chief Fin. Officer and EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,837

F1 · shares: Represents restricted stock units ("RSUs") that vest on December 31, 2021, subject to the Reporting Person's continuous service through such vesting date. Each RSU represents a contingent right to receive one share of Common Stock.

F2 · balance_after: This amount includes 672 shares acquired on June 30, 2020 under the Tricida, Inc. 2018 Employee Stock Purchase Plan. This acquisition is exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from Section 16(a) pursuant to Rule 16a-3(f)(1)(i)(B).

SEC source: 0001209191-21-007911 · doc5.xml · nonDerivative · entry 1

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Geoffrey M Parker & Jill Gofen Parker Trustees of Geoffrey M Parker & Jill G Parker Revocable Trust

Disclosed balance after: 44,600

SEC source: 0001209191-20-032210 · doc4.xml · derivative · entry 6

Parker Geoffrey M. · CIK 0001491874 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,724 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F4 · price: Each restricted stock unit represents a contingent right to receive one share of CCXI common stock.

F6 · derivative.exercise_date: 100% of the restricted stock units vested on May 23, 2020. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.

F6 · derivative.expiration_date: 100% of the restricted stock units vested on May 23, 2020. Vested shares will be delivered to the Reporting Person within thirty (30) days following vest date.